Azithromycin - Important Safety Information from Pfizer Limited, Aspire Pharma Limited, Krka Pharma Dublin Ltd, Teva and Wockhardt UK Limited as approved by the HPRA

Notice type: 3rd Party Publications

Date: 03/05/2018

Important Safety Information communication from Pfizer Limited, Aspire Pharma Limited, Krka Pharma Dublin Ltd, Teva and Wockhardt UK Limited on increased rate of relapses of haematological malignancies and mortality in

hematopoietic stem cell transplantation (HSCT) patients treated with Azithromycin

Important Safety Information - Azithromycin